Brain-Derived Neurotrophic Factor and Delayed Verbal Recall in Crack/Cocaine Dependents

European Addiction Research

Volumn 21, Issue 5, 2015, Pages 273-278

  Viola, Thiago Wendt ^a   Tractenberg, Saulo Gantes ^a   Kluwe Schiavon, Bruno ^a   Levandowski, Mateus Luz ^a   Sanvicente Vieira, Breno ^a   Wearick Silva, Luis Eduardo ^a   De Azeredo, Lucas Araújo ^a   Teixeira, Antônio Lucio ^b   Grassi Oliveira, Rodrigo ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

BDNF; Cocaine relapse; Memory; Neurotrophin; Treatment outcome

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COCAINE DEPENDENCE; CONTROLLED STUDY; DELAYED VERBAL RECALL; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MEMORY ASSESSMENT; MEMORY CONSOLIDATION; MEMORY DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WECHSLER MEMORY SCALE; WITHDRAWAL SYNDROME; BLOOD; CASE CONTROL STUDY; COMPLICATION; DRUG EFFECTS; PSYCHOLOGY; RECALL; YOUNG ADULT;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; COCAINE-RELATED DISORDERS; CRACK COCAINE; DEPRESSION; FEMALE; HUMANS; MEMORY DISORDERS; MENTAL RECALL; YOUNG ADULT;

EID: 84930267979     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000430436     Document Type: Article

References (50)

1. George O, Koob GF: Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev 2010; 35: 232-247.
2. Johnson-Greene D, Adams KM, Gilman S, Junck L: Relationship between neuropsychological and emotional functioning in severe chronic alcoholism. Clin Neuropsychol 2002; 16: 300-309.
3. Gould TJ: Addiction and cognition. Addict Sci Clin Pract 2010; 5: 4-14.
4. Di Sclafani V, Tolou-Shams M, Price LJ, Fein G: Neuropsychological performance of individuals dependent on crack-cocaine, or crackcocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend 2002; 66: 161-171.
5. van Gorp WG, Wilkins JN, Hinkin CH, Moore LH, Hull J, Horner MD, et al: Declarative and procedural memory functioning in abstinent cocaine abusers. Arch Gen Psychiatry 1999; 56: 85-89.
6. Viola TW, Tractenberg SG, Pezzi JC, Kristensen CH, Grassi-Oliveira R: Childhood physical neglect associated with executive functions impairments in crack cocaine-dependent women. Drug Alcohol Depend 2013; 132: 271-276.
7. De Oliveira LG, Barroso LP, Silveira CM, Sanchez ZV, De Carvalho Ponce J, Vaz LJ, et al: Neuropsychological assessment of current and past crack cocaine users. Subst Use Misuse 2009; 44: 1941-1957.
8. Cunha PJ, Bechara A, de Andrade AG, Nicastri S: Decision-making deficits linked to reallife social dysfunction in crack cocaine-dependent individuals. Am J Addict 2011; 20: 78-86.
9. Viola TW, Tractenberg SG, Levandowski ML, Pezzi JC, Bauer ME, et al: Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress. J Psychiatry Neurosci 2013; 38: 130027.
10. Gunstad J, Benitez A, Smith J, Glickman E, Spitznagel MB, Alexander T, et al: Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. J Geriatr Psychiatry Neurol 2008; 21: 166-170.
11. Gama CS, Andreazza AC, Kunz M, Berk M, Belmonte-de-Abreu PS, Kapczinski F: Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett 2007; 420: 45-48.
12. Hong CJ, Liou YJ, Tsai SJ: Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res Bull 2011; 86: 287-297.
13. Vinberg M, Miskowiak K, Kessing LV: Brain derived neurotrophic factor (BDNF) levels as a possible predictor of psychopathology in healthy twins at high and low risk for affective disorder. Psychoneuroendocrinology 2014; 39: 179-183.
14. Bekinschtein P, Cammarota M, Medina JH: BDNF and memory processing. Neuropharmacology 2014; 76: 677-683.
15. Grassi-Oliveira R, Stein LM, Lopes RP, Teixeira AL, Bauer ME: Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression -a preliminary report. Biol Psychiatry 2008; 64: 281-285.
16. Oral E, Canpolat S, Yildirim S, Gulec M, Aliyev E, Aydin N: Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder. Brain Res Bull 2012; 88: 454-459.
17. Dias VV, Brissos S, Frey BN, Andreazza AC, Cardoso C, Kapczinski F: Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord 2009; 11: 663-671.
18. Ruiz de Azua S, Matute C, Stertz L, Mosquera F, Palomino A, de la Rosa I, et al: Plasma brainderived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis. BMC Psychiatry 2013; 13: 27.
19. Zhang XY, Liang J, Chen da C, Xiu MH, Yang FD, Kosten TA, et al: Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology (Berl) 2012; 222: 277-284.
20. Kapczinski F, Frey BN, Kauer-Sant'Anna M, Grassi-Oliveira R: Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother 2008; 8: 1101-1113.
21. Schmidt HD, Sangrey GR, Darnell SB, Schassburger RL, Cha JH, Pierce RC, et al: Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem 2012; 120: 202-209.
22. Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW: Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 2007; 10: 1029-1037.
23. Tsai SJ: Increased central brain-derived neurotrophic factor activity could be a risk factor for substance abuse: implications for treatment. Med Hypotheses 2007; 68: 410-414.
24. D'Sa C, Fox HC, Hong AK, Dileone RJ, Sinha R: Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study. Biol Psychiatry 2011; 70: 706-711.
25. von Diemen L, Kapczinski F, Sordi AO, de Magalhães Narvaez JC, Guimarães LS, Kessler FH, et al: Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal. Int J Neuropsychopharmacol 2014; 17: 33-40.
26. Corominas-Roso M, Roncero C, Eiroa-Orosa FJ, Gonzalvo B, Grau-Lopez L, Ribases M, et al: Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence. Eur Neuropsychopharmacol 2013; 23: 1078-1084.
27. First MB: Structured Clinical Interview for DSM-IV Axis I Disorders: SCID -I: Clinician Version: Administration Booklet. Washington, DC, American Psychiatric Press, 1997.
28. Gomes-Oliveira MH, Gorenstein C, Lotufo Neto F, Andrade LH, Wang YP: Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample. Rev Bras Psiquiatr 2012; 34: 389-394.
29. Kampman KM, Volpicelli JR, McGinnis DE, Alterman AI, Weinrieb RM, D'Angelo L, et al: Reliability and validity of the cocaine selective severity assessment. Addict Behav 1998; 23: 449-461.
30. Willett WC, Howe GR, Kushi LH: Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997; 65: 1220S-1228S; discussion 1229S-1231S.
31. Wechsler D: The Wechsler Memory Scale. San Antonio, TX, The Psychological Corporation, 1987.
32. Abi-Saab D, Beauvais J, Mehm J, Brody M, Gottschalk C, Kosten TR: The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjects. Am J Addict 2005; 14: 166-178.
33. Serper MR, Bergman A, Copersino ML, Chou JC, Richarme D, Cancro R: Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients. Psychiatry Res 2000; 93: 21-32.
34. Horner MD: Cognitive functioning in alcoholic patients with and without cocaine dependence. Arch Clin Neuropsychol 1997; 12: 667-676.
35. Tractenberg SG, Viola TW, Gomes CF, Wearick- Silva LE, Kristensen CH, Stein LM, et al: Dual-memory processes in crack cocaine dependents: the effects of childhood neglect on recall. Memory 2014; 24: 1-17.
36. Mittenberg W, Motta S: Effects of chronic cocaine abuse on memory and learning. Arch Clin Neuropsychol 1993; 8: 477-483.
37. Narvaez JC, Magalhães PV, Fries GR, Colpo GD, Czepielewski LS, Vianna P, et al: Peripheral toxicity in crack cocaine use disorders. Neurosci Lett 2013; 544: 80-84.
38. Mao LM, Fibuch EE, Wang JQ: Decoding BDNF-LTP coupling in cocaine addiction. Neuron 2010; 67: 679-681.
39. Lang UE, Hellweg R, Seifert F, Schubert F, Gallinat J: Correlation between serum brainderived neurotrophic factor level and an in vivo marker of cortical integrity. Biol Psychiatry 2007; 62: 530-535.
40. Cleck JN, Ecke LE, Blendy JA: Endocrine and gene expression changes following forced swim stress exposure during cocaine abstinence in mice. Psychopharmacology (Berl) 2008; 201: 15-28.
41. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, et al: Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003; 23: 6690-6694.
42. Bekinschtein P, Cammarota M, Izquierdo I, Medina JH: BDNF and memory formation and storage. Neuroscientist 2008; 14: 147-156.
43. Alonso M, Bekinschtein P, Cammarota M, Vianna MR, Izquierdo I, Medina JH: Endogenous BDNF is required for long-term memory formation in the rat parietal cortex. Learn Mem 2005; 12: 504-510.
44. Geisel O, Banas R, Hellweg R, Müller CA: Altered serum levels of brain-derived neurotrophic factor in patients with pathological gambling. Eur Addict Res 2012; 18: 297-301.
45. Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, et al: Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 2011; 14: 347-353.
46. Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, et al: Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 2009; 42: 270-276.
47. Zhen YF, Zhang J, Liu XY, Fang H, Tian LB, Zhou DH, et al: Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology (Berl) 2013; 227: 93-100.
48. Wu JQ, Chen da C, Tan YL, Tan SP, Hui L, Lv MH, et al: Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia. Psychopharmacology (Berl) 2015; 232: 223-232.
49. García-Mesa Y, Pareja-Galeano H, Bonet- Costa V, Revilla S, Gómez-Cabrera MC, Gambini J, et al: Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms. Psychoneuroendocrinology 2014; 45: 154-166.
50. Melo CV, Okumoto S, Gomes JR, Baptista MS, Bahr BA, Frommer WB, et al: Spatiotemporal resolution of BDNF neuroprotection against glutamate excitotoxicity in cultured hippocampal neurons. Neuroscience 2013; 237: 66-86.